Absci and AMD Announce Collaboration and Strategic Investment …
Jan 8, 2025 · Absci and AMD will showcase the exceptional performance of AMD’s Instinct accelerators in addressing complex biological applications, including Absci’s proprietary IgDesign1 model, the first in vitro validated inverse folding model for antibody design.
Analyst Praises AMD-Partner Absci's Practical Approach, Sees …
4 days ago · Needham has initiated with a Buy rating and a price forecast of $9.Blum writes that Absci builds its value through proprietary assets it develops in-house, such as ABS-101, 201, 301, and 501.
Absci partners with semiconductor company AMD for AI drug …
5 days ago · Absci, a data-first generative AI drug-creation company, is partnering with AMD, a semiconductor company, to deploy AMD Instinct accelerators and ROCm software to power vital AI drug-discovery workloads, as well as Absci's advanced De Novo antibody-design models.
AMD is going head-to-head with Nvidia in AI-backed drug …
Jan 8, 2025 · Advanced Micro Devices Inc. is going head-to-head with bigger rival Nvidia Corp. in artificial intelligence-backed drug discovery with news of a new partnership and investment in startup Absci...
Absci Secures $20M AMD Investment, Strategic AI Drug Discovery ...
Jan 8, 2025 · AMD invests in Absci through PIPE deal, providing advanced Instinct accelerators to power AI-driven antibody design. Partnership aims to enhance drug discovery capabilities.
Absci Stock Jumps As AMD Invests $20M To Boost AI Drug …
Jan 8, 2025 · AI drug creation company Absci Corporation (NASDAQ: ABSI) shares are trading higher in premarket on Wednesday after the company entered into a strategic collaboration with Advanced Micro Devices...
AMD invests $20M in AI-powered drug discovery company Absci
Jan 8, 2025 · Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop new hardware and software optimized for the healthcare sector.
AMD invests $20 million in Absci to expand AI chip sales in …
Jan 8, 2025 · Investing.com -- Advanced Micro Devices (NASDAQ: AMD) is set to invest $20 million in Absci, a Washington-based drug-discovery firm, aiming to increase the use of its artificial...
Absci, AMD announce collaboration, strategic investment
Jan 8, 2025 · Absci Corporation (ABSI) announced a strategic collaboration with AMD (AMD) to deploy AMD Instinct accelerators and ROCm software to power critical AI drug discovery workloads, including...
AMD invests $20 million in AI drug discovery firm Absci - Investing.com
Jan 8, 2025 · VANCOUVER, Wash. - Absci Corporation (NASDAQ: ABSI), a generative AI drug creation company with a market capitalization of $353 million, announced a strategic collaboration with Advanced Micro...